Evidence map›Paper›PMID 27355625›Full record

ArticlePloS one2016

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.

Giovanni Bacci, Patrizia Paganin, Loredana Lopez, Chiara Vanni, Claudia Dalmastri, Cristina Cantale, Loretta Daddiego, Gaetano Perrotta, Daniela Dolce, Patrizia Morelli and 7 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gender differences in bronchiectasis: a real issue?Breathe (Sheffield, England) · 2018
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Giovanni BacciDepartment of Biology, University of Florence, Florence, Italy.
Patrizia PaganinDepartment for Sustainability of Production and Territorial Systems, Biotechnologies and Agro-Industry Division, ENEA Casaccia Research Center, Rome, Italy.
Loredana LopezDepartment of Energy Technologies, Bioenergy, Biorefinery and Green Chemistry Division, ENEA Trisaia Research Center, Rotondella (MT), Italy.
Chiara VanniDepartment of Biology, University of Florence, Florence, Italy.
Claudia DalmastriDepartment for Sustainability of Production and Territorial Systems, Biotechnologies and Agro-Industry Division, ENEA Casaccia Research Center, Rome, Italy.
Cristina CantaleDepartment for Sustainability of Production and Territorial Systems, Biotechnologies and Agro-Industry Division, ENEA Casaccia Research Center, Rome, Italy.
Loretta DaddiegoDepartment of Energy Technologies, Bioenergy, Biorefinery and Green Chemistry Division, ENEA Trisaia Research Center, Rotondella (MT), Italy.
Gaetano PerrottaDepartment of Energy Technologies, Bioenergy, Biorefinery and Green Chemistry Division, ENEA Trisaia Research Center, Rotondella (MT), Italy.
Daniela DolceDepartment of Pediatrics, Cystic Fibrosis Center, Meyer Hospital, Florence, Italy.
Patrizia MorelliDepartment of Pediatrics, Cystic Fibrosis Center, G. Gaslini Institute, Genoa, Italy.
Vanessa TuccioCystic Fibrosis Microbiology and Cystic Fibrosis Center, Children's Hospital and Research Institute Bambino Gesù, Rome, Italy.
Alessandra De AlessandriDepartment of Pediatrics, Cystic Fibrosis Center, G. Gaslini Institute, Genoa, Italy.
Ersilia Vita FiscarelliCystic Fibrosis Microbiology and Cystic Fibrosis Center, Children's Hospital and Research Institute Bambino Gesù, Rome, Italy.
Giovanni TaccettiDepartment of Pediatrics, Cystic Fibrosis Center, Meyer Hospital, Florence, Italy.
Vincenzina LucidiCystic Fibrosis Microbiology and Cystic Fibrosis Center, Children's Hospital and Research Institute Bambino Gesù, Rome, Italy.
Annamaria BevivinoDepartment of Biology, University of Florence, Florence, Italy.ORCID http://orcid.org/0000-0003-4277-7048
Alessio MengoniDepartment of Biology, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic airway infection is a hallmark feature of cystic fibrosis (CF) disease. In the present study, sputum samples from CF patients were collected and characterized by 16S rRNA gene-targeted approach, to assess how lung microbiota composition changes following a severe decline in lung function. In particular, we compared the airway microbiota of two groups of patients with CF, i.e. patients with a substantial decline in their lung function (SD) and patients with a stable lung function (S). The two groups showed a different bacterial composition, with SD patients reporting a more heterogeneous community than the S ones. Pseudomonas was the dominant genus in both S and SD patients followed by Staphylococcus and Prevotella. Other than the classical CF pathogens and the most commonly identified non-classical genera in CF, we found the presence of the unusual anaerobic genus Sneathia. Moreover, the oligotyping analysis revealed the presence of other minor genera described in CF, highlighting the polymicrobial nature of CF infection. Finally, the analysis of correlation and anti-correlation networks showed the presence of antagonism and ecological independence between members of Pseudomonas genus and the rest of CF airways microbiota, with S patients showing a more interconnected community in S patients than in SD ones. This population structure suggests a higher resilience of S microbiota with respect to SD, which in turn may hinder the potential adverse impact of aggressive pathogens (e.g. Pseudomonas). In conclusion, our findings shed a new light on CF airway microbiota ecology, improving current knowledge about its composition and polymicrobial interactions in patients with CF.

Indexed as

MicrobiotaAdolescentAdultChildCystic FibrosisEcologyFemaleHumansItalyLungMaleMiddle AgedPhylogenyPrevotellaPseudomonasRespiratory Function TestsRNA, Ribosomal, 16S

Identifiers

PMID27355625
PMCPMC4927098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.